Toggle navigation
About Bio-Path
Leadership Team
Board of Directors
Scientific Advisory Board
Partnering Opportunities
Technology
Pipeline
Prexigebersen
BP1002
BP1003
Investors
Analyst Coverage
SEC Filings
Corporate Governance
Media
Press Releases
Events
Presentations & Publications
Careers
Contact Us
SEC Filings
Analyst Coverage
SEC Filings
Corporate Governance
Recent Posts
SEC Form 424B5: Prospectus Supplement (To Prospectus Dated June 5, 2019)
Feb 17 2021
SEC Form 8K: Entry Into a Material Definitive Agreement and Press Release dated February 16, 2021
Feb 17 2021
SEC Form 8K: Press Release Dated February 10, 2021
Feb 11 2021
SEC Form 8K: Press Release Dated December 18, 2020: Submission of Matters to a Vote of Security Holders
Dec 18 2020
SEC Form 8K: Press Release Dated November 19, 2020
Nov 20 2020
SEC Form 8K: Press Release Dated November 13, 2020
Nov 13 2020
SEC Form 10-Q for period ending September 30, 2020
Nov 13 2020
Interactive Data Files
Download Zipped Files
Nov 13 2020
Proxy Notice Card
Nov 5 2020
Proxy Statement
Nov 5 2020
Show More Posts
Loading...
Corporate Governance
View Our Corporate Governance
Delivering a Better Path for Cancer Patients.